Future work in our laboratory aims to investigate more thoroughly the incidence and influence of upregulated KCa3.1 channels in the context of cervical cancer to determine if, and to what degree, this protein might constitute a therapeutic target in its own right. This evidence concerns the gene KCNN4 and cervical cancer.